Valion Bio, Inc. Common Stock

VBIONASDAQ • USD
ThemeBiotech - Drug Development›Immunology & Autoimmune
0.51 USD
↘ 0.01 (1.76%)🟢LIVE (AS OF 09:27 AM EST)
🟢Market: OPEN

Valion Bio, Inc. Common Stock (VBIO) trades at $0.51 per share. Technical indicators currently signal "Sell". Key drivers include negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. VBIO is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Nov 4, 2026.

Open?$0.51
High?$0.51
Low?$0.51
Prev. Close?$0.52
Volume?1.9K
Avg. Volume?3.3M
VWAP?$0.51
Rel. Volume?0.00x
Bid / Ask
Bid?$0.43 × 100
Ask?$0.59 × 100
Spread?$0.15
Midpoint?$0.51
Valuation & Ratios
Market Cap?1.1M
Shares Out?2.2M
Float?1.3M
Float %?99.6%
P/E Ratio?N/A
P/B Ratio?0.26
EPS?-$7.82
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.
Themes
Biotech - Drug Development›Immunology & AutoimmuneHealthcare - Oncology›Immunotherapy & Immuno-Oncology
Employees
52
Market Cap
1.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.tivichealth.com
Listed
2021-11-11
Address
1305 E. HOUSTON STREET
SAN ANTONIO, TX 78205
Phone: (888)276-6888
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestElevated
Short % of Float?9.02%Elevated
Short Interest?115.5K
Days to Cover?1.0
Free Float1.3M
Avg Daily Volume1.4M
Settlement Date2026-10-15
Financial Health
Current Ratio?1.13Adequate
Quick Ratio?0.88Weak
Cash Ratio?0.70Adequate
Debt/Equity?1.74High
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.26CHEAP▾
P/S?
Peers
100
S&P
15
7.46HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.5CHEAP▾
EV/Sales?
Peers
100
S&P
3
43.63HIGH▾
Returns & Efficiency
ROE?
S&P
3
-385.8%WEAK▾
ROA?
S&P
3
-50.4%WEAK▾
Cash Flow & Enterprise
FCF?$-14674000
Enterprise Value?$6.4M
Fundamentals ratios updated end of day
MarketsMoversWatchlist